Ann: Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer, page-14

Also for others, it's synthetic/new so likely the manufacturing is also spinning up its processes for the first time.

might be also worth a highlight about also current products

(even the current products that are given under the sasb model don't deliver what they say on the bottle - there was a study where most were way off what they said on the label ----- > which is why we are going registered path over them you can't fake new people for true medical conditions unlike the current access with 'unapproved' products).